Cryoport vs Mesa Laboratories
Mesa Laboratories reported revenue of $249 million in fiscal 2026, 1.4 times Cryoport's $176 million in fiscal 2025. Cryoport's revenue grew 12.4% in its latest year, and Mesa Laboratories' grew 3.4%. Cryoport had an operating margin of -20.9%, against 7.4% at Mesa Laboratories. Free cash flow was −$25 million at Cryoport and $40 million at Mesa Laboratories. Their fiscal years end in different months (December 31 and March 31), so the periods don't line up exactly.
Side by side
| Cryoport | Mesa Laboratories | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Mar 31, 2026 |
| Revenue | $176M | $249M |
| Revenue growth | 12.4% | 3.4% |
| Revenue growth a year, last 5 years | 17.5% | 13.2% |
| Gross margin | 47.1% | 63.5% |
| Operating margin | −20.9% | 7.4% |
| Net margin | 44.4% | 2.7% |
| Free cash flow | −$25M | $40M |
| Free cash flow margin | −14.2% | 15.9% |
| Return on capital | −23.4% | 4.8% |
| Net debt to EBITDA | — | 1.0x |
| Dividends and buybacks | $10M | $4M |
| Change in diluted share count | 1.5% | 2.7% |
| Last close | $19.89 | $139.01 |
| P/E at the last close | — | 120.9× |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | 4 of 9 | 8 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CryoportMesa Laboratories
Operating margin
Percent of revenue
CryoportMesa Laboratories
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CryoportMesa Laboratories
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cryoport and Mesa Laboratories pages.